ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Funding Opportunities
Food and Drug AdministrationDepartment of Health and Human Services

Preventative Maintenance of Above Standard Equipment (ASE) FDA National Capital Region

Funder: United States Food and Drug Administration

Posted Nov 21, 2026·Last checked Nov 22, 2026·open

AGENCY

Food and Drug Administration

PROGRAM

Presolicitation

AMOUNT

—

CLOSES

Dec 4, 2026

Description

The Food and Drug Administration (FDA), Office of Acquisitions and Grants Services, Facilities Procurement Branch, intends to issue Request for Proposal 75F40127R00002 for Preventive Maintenance of Above Standard Equipment at FDA facilities in the National Capital Region. The primary place of performance is the FDA White Oak Campus, Silver Spring, Maryland; the contract will also cover other FDA locations in the District of Columbia, Maryland, and Virginia identified in the Site List, which may be added to during the ordering period. The requirement covers program management; preventive, predictive, and corrective maintenance; repair; calibration and certification; after hours emergency response; and Site Scan monitoring support for laboratory, scientific, animal care, and facility support equipment. This is a recompete of contract 75F40122D00031. The Government anticipates a single-award indefinite-delivery indefinite-quantity contract with one five-year ordering period and firm-fixed-price orders, awarded under FAR Part 12 commercial procedures with Part 15 source selection on a best value tradeoff basis. The acquisition is anticipated to be a total small business set-aside under NAICS 811210, Electronic and Precision Equipment Repair and Maintenance, size standard $34 million. The RFP is expected to post to SAM.gov in mid to late December 2026 with a 30-day response period; proposals are anticipated to be due in mid to late January 2027. Attendance at a mandatory site visit and reading room session in early January 2027 will be a condition of proposal consideration; the RFP will state the date, registration procedure, and non-disclosure requirements, and the equipment list and site list will be available only in the reading room. Anticipated evaluation factors are Corporate Experience, Technical Approach, Management Approach including Key Personnel, Past Performance, and Price, with non-price factors significantly more important than price. This notice is for planning purposes only. It is not a solicitation and no proposals are requested or will be accepted at this time. Questions will be accepted only as provided in the RFP. Interested firms must be registered in SAM.gov.

Eligibility

Small Business Set Aside - Total

Contact

Iris Johnson

Iris.Johnson1@fda.hhs.gov

3017963353

Additional details

Department
Department of Health and Human Services
Sub-tier
Food and Drug Administration
Office
FDA Office of Acq Grant Svcs
NAICS code
811210
Set-aside
SBA
Place of performance
Silver Spring, MD, USA
Archived
Dec 19, 2026

Opportunity number: 75F40127R00002

Quote this number when you contact the agency or apply.